The company, owned by private-equity firm Hellman & Friedman, has hired Credit Suisse Group, Barclays and Goldman Sachs to lead the offering.
An IPO would mark a return to the public markets for Sheridan, which was taken private by Vestar Capital Partners in 1999 for about $155 million, according to the report.
More Articles on Anesthesia:
Crystal Clear Solutions Develops Anesthesia Guide App for Surgical Procedures
AllCare Clinical Associates Appoints Dr. Frank Sutton as Partner
University of Michigan Health Startup Receives FDA Clearance for Patient Monitoring Software
